Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Retained Earnings (2022 - 2025)

Envoy Medical's Retained Earnings history spans 4 years, with the latest figure at -$313.4 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$313.4 million for Q4 2025, down 10.07% from a year ago — trailing twelve months through Dec 2025 was -$313.4 million (down 10.07% YoY), and the annual figure for FY2025 was -$313.4 million, down 10.07%.
  • Retained Earnings for Q4 2025 was -$313.4 million at Envoy Medical, down from -$305.7 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$17.4 million in Q3 2022 to a low of -$313.4 million in Q4 2025.
  • The 4-year median for Retained Earnings is -$261.1 million (2023), against an average of -$196.4 million.
  • Peak annual rise in Retained Earnings hit 20.74% in 2023, while the deepest fall reached 1346.57% in 2023.
  • Year by year, Retained Earnings stood at -$226.0 million in 2022, then fell by 13.84% to -$257.3 million in 2023, then fell by 10.68% to -$284.7 million in 2024, then decreased by 10.07% to -$313.4 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$313.4 million, -$305.7 million, and -$297.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.